Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Sun J, Sukhova GK, Yang M, Wolters PJ, MacFarlane LA, Libby P, et al
Quantity (kits) See full tier pricing Order total $72 Research Specifications Purity 99% HPLC Form Lyophilized powder Storage 20C, desiccated Kit 10 vials per kit Frequently bought together Complete your workflow save 10% when bundled
Effects of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial Tesamorelin, a growth hormone-releasing factor analogue, in HIV-infected patients with excess abdominal fat Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in HIV-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials Pharmacokinetics, pharmacodynamics, and safety of ipamorelin, a novel ghrelin mimetic peptide, in healthy volunteers Ipamorelin, the first selective growth hormone secretagogue Growth hormone-releasing hormone in the treatment of HIV-associated lipodystrophy Eligibility & terms of sale This material is sold to qualified laboratory and research buyers for lawful research use only
Indeed, IGF-IR inhibition sensitizes cancer cells to ATM-related kinase inhibition, cisplatin, oxaliplatin, and doxorubicin [96,97,98,99]
This ensures controlled dosage and maximum efficacy but requires clinic visits and higher costs
S., & Lenihan, D
US$ 28.80
US$ 25.95
US$ 23.10
US$ 20.01
US$ 26.75
US$ 27.70
US$ 22.43
US$ 25.67
US$ 29.59